IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes
- 6 February 2012
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 167 (2) , 464-469
- https://doi.org/10.1016/j.ijcard.2012.01.018
Abstract
No abstract availableKeywords
Funding Information
- The Swedish Heart Lung Foundation
- Swedish Research Council
- CIDaT
- European Union
- Karolinska Institutet
- Stockholm County Council
- Västra Götaland Region
- Vårdal foundation
- Göteborg University
- Göteborg Medical Society
This publication has 40 references indexed in Scilit:
- Prognostic Utility of Secretory Phospholipase A2 in Patients with Stable Coronary Artery DiseaseClinical Chemistry, 2011
- Oxidation-Specific Epitopes Are Danger-Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate ImmunityCirculation Research, 2011
- Low Levels of Antibodies Against Phosphorylcholine Predict Development of Stroke in a Population-Based Study From Northern SwedenStroke, 2010
- Inflammation in AtherosclerosisJournal of the American College of Cardiology, 2009
- Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humansJournal of Clinical Investigation, 2009
- Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque developmentNature Medicine, 2008
- Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null miceAtherosclerosis, 2006
- Innate and acquired immunity in atherogenesisNature Medicine, 2002
- Active and Passive Smoking, Chronic Infections, and the Risk of Carotid AtherosclerosisStroke, 2002
- Phosphorylcholine: friend or foe of the immune system?Published by Elsevier ,1999